stockrow
Friday 6 November 2026
Export PMI’s income statement to Excel — free account
Flag Ship Acquisition Corp
PMI Healthcare Medical Devices
Flag Ship Acquisition Corp’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, up 12.5% from fiscal 2024.
- Revenue
- +38.6%
- EPS
- +92.8%
- Free cash flow
- +46.8%
- Total debt
- −89.8%
Quarter to June 2026, against a year earlier
9.00
1.15
+14.65%
Follow PMI
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+5 more quarters Free account |
P/S ratio |
2.41 | 14.15 | 12.84 | 96.04 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(11.23) | (20.37) | (14.49) | (71.05) | |
P/B ratio |
8.85 | 0.00 | 16.74 | 58.09 | |
Price to Tangible BV |
23.87 | 0.00 | 23.79 | 67.84 | |
EV/Sales |
2.52 | 14.26 | 10.73 | 96.88 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.99) | (4.53) | (3.38) | (32.31) | |
EV/FCF |
(0.99) | (4.53) | (3.38) | (32.31) | |
Quick Ratio |
0.09 | 0.06 | 0.65 | 0.74 | |
Current Ratio |
1.02 | 0.75 | 1.11 | 2.16 | |
Net Debt/EBITDA |
(0.15) | (0.13) | 3.63 | 2.29 | |
Debt/Assets |
7.64% | 6.32% | 4.57% | 0.33% | |
Debt/Equity |
0.41 | (0.49) | 0.27 | 0.01 | |
Asset Turnover |
0.60 | 0.98 | 0.44 | 0.71 | |
Operating CF/Net income |
0.24 | 0.50 | 1.02 | 0.62 | |
Capex/Depreciation |
0.00 | (0.19) | 0.00 | 0.00 | |
Interest Coverage |
(52.01) | (902.20) | (429.00) | (1.45) | |
Research and Development Expense of Revenue |
46.51% | 164.78% | 54.59% | 80.12% | |
Selling, General and Administrative Expense of Revenue |
131.04% | 251.39% | 286.13% | 202.70% | |
Intangible Assets out of Total Assets |
0.12 | 0.10 | 0.05 | 0.08 | |
Share Based Compensation of Revenue |
46.72% | 14.35% | 22.55% | 17.19% | |
Graham Net Nets |
0.01 | (0.04) | 0.03 | 0.01 | |
Graham Number |
0.00 | 36.21 | 0.00 | 0.00 | |
Earnings Yield |
(250.12%) | (115.21%) | (108.47%) | (30.84%) | |
Free Cash Flow Yield |
(105.68%) | (22.26%) | (24.72%) | (3.12%) | |
Revenue per Share |
1.59 | 0.77 | 1.38 | 1.09 | |
Operating CF per Share |
(0.73) | (2.55) | (6.04) | (5.98) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.73) | (2.57) | (6.04) | (5.98) | |
Cash per Share |
0.02 | 0.08 | 15.80 | 2.58 | |
Shareholders Equity per Share |
0.92 | (0.97) | 5.23 | 7.32 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.92 | (0.97) | 5.23 | 7.32 | |
Free Cash Flow |
(1.35) | (3.83) | (4.38) | (6.51) | |
Working Capital |
0.14 | (3.15) | 2.03 | 6.22 | |
Capital Expenditures |
0.00 | (0.03) | — | — | |
Net Current Asset Value |
0.14 | (3.16) | 1.97 | 6.04 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.02 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.01 | 0.61 | — | — | |
Average Payables |
4.85 | 4.00 | — | — | |
Average Inventory |
6.48 | 7.78 | — | — | |
Average Assets |
10.44 | 5.61 | 11.27 | 6.76 | |
Average Common Equity |
(26.39) | (22.72) | — | — |
Columns are period end dates · fundamentals updated 26 Oct 2026